ClinicalTrials.Veeva

Menu

Multidisciplinary Follow-up of Patients Treated for Malignant Hematological Disease

A

Aalborg University Hospital

Status

Unknown

Conditions

Malignant Hematologic Neoplasm

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this study is to adjust and test an existing internet-based tool for collecting patient-reported outcome measures and to use the internet-based tool in an multidisciplinary follow-up of patients treated for malignant hematological diseases. The patient-reported outcome measurements will be used in describing the patients' health-related quality of life (HRQoL) and to investigate whether the HRQol will increase due to participation in multidisciplinary follow-up.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients diagnosed with malignant hematological disease; Morbus Hodgkin and B- and T-cell disease
  • patients followed before or after 1. line treatment
  • patients in stable phase > 6 months after 1. line treatment
  • the patients participation in the study must be assessed and decided by the doctor responsible for the patient's course of treatment

Exclusion criteria

  • Health conditions which demands close medical monitoring
  • conditions which compromise the ability to understand the study and submit informed consent (ex.: dementia and severe mental illness / disability)
  • lack of capability to fill out electronic questionnaires
  • poor self-care and/or compliance

Trial contacts and locations

1

Loading...

Central trial contact

Mia Sommer, MHsc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems